Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113149851A details a high-yield 4-step synthesis for stable isotope labeled chlorpropaline, offering cost-effective solutions for residue detection.
Advanced preparation of Tenofovir Disoproxil degradation impurity via selective hydrolysis. Enhancing API quality control and supply chain stability for global pharma.
Patent CN101245049A offers improved Palbendazole synthesis with reduced waste and cost for veterinary supply chains.
Patent CN105017035B details a high-purity DKR method for chiral intermediates. Achieves >99% ee with scalable catalysts for reliable pharmaceutical supply chains.
Patent CN108409626A details a novel route for Rucaparib intermediates offering enhanced purity and cost efficiency for global pharmaceutical supply chains.
Patent CN115677587B enables high-purity antiviral intermediate production. Safe scalable process ensures reliable supply chain and significant cost efficiency.
Novel patent CN110627683A offers safe, high-purity 4-cyano-1-indanone synthesis. Eliminates toxic cyanating reagents for cost-effective pharmaceutical intermediate manufacturing.
Discover a novel purification method for Indacaterol intermediates using m-chlorobenzoic acid, offering higher yield and purity for reliable API intermediate supply chains.
Novel gold-catalyzed synthesis of indanone imine derivatives with potent anti-tumor activity. Efficient route for API intermediates ensuring cost reduction and supply stability.
Advanced electroluminescent materials via Buchwald-Hartwig coupling. High purity, scalable synthesis for display applications. Cost-effective manufacturing solutions.
Novel two-step route ensures stable deuteration and high purity for forensic analysis, offering significant cost and supply chain advantages for global laboratories.
Patent CN117003642A reveals a novel route for Ensitrelvir intermediates. Achieve high purity and reduced costs with scalable pharmaceutical intermediate manufacturing strategies.
Novel patent CN110128347A enables high-purity indazole intermediate production with scalable carbonylation technology for reliable pharmaceutical supply chains.
Novel chiral resolution route for Levosimendan intermediates ensures high optical purity and scalable production for global pharmaceutical supply chains.
Patent CN106432199B reveals ultrasonic resolution for high-purity Ondansetron. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Efficient iron-catalyzed synthesis of 3-aroylindanone-2-carboxylates offering cost reduction and scalable pharmaceutical intermediate manufacturing solutions.
Advanced solid phosgene method for high-purity clindamycin intermediate. Reduces cost and improves safety for pharmaceutical manufacturing supply chains.
Patent CN108690100B reveals a novel purification strategy for fondaparinux sodium intermediates, enabling high-purity production and significant cost reduction in pharmaceutical manufacturing.
Novel synthesis route for 4-aminoindan derivatives via reversed hydrogenation-acylation sequence, offering significant cost reduction in fungicide manufacturing and enhanced supply chain reliability.
Patent CN103122012B reveals a streamlined synthesis for fondaparinux sodium intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.